Viewing Study NCT00003560


Ignite Creation Date: 2025-12-25 @ 2:13 AM
Ignite Modification Date: 2025-12-26 @ 12:41 AM
Study NCT ID: NCT00003560
Status: UNKNOWN
Last Update Posted: 2014-01-06
First Post: 1999-11-01
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Docetaxel Plus Carboplatin in Treating Patients With Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Sponsor: Herbert Irving Comprehensive Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module